As per this study, the Global mRNA Vaccine And Therapeutics Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2027 with a CAGR of XX%.
mRNA vaccine is the drugs prepared using advanced technologies using mRNA as the genetic material. mRNA vaccines are a more efficient alternative owing to their enhanced immunogenicity, higher potency, rapid development, relatively cheaper and safer over conventional vaccines. These are gaining high importance to reduce the incidence of cancer and infectious diseases like measles, smallpox and a wide range of pathogens such as Ebola, influenza, HIV, etc.
Rising adoption of mRNA vaccine owing to its higher efficiency and shorter manufacturing times is driving the market growth. Rising licensing agreements between mRNA vaccine manufacturers, and prominent vaccine developers’ to offer advanced infectious disease vaccination is further boosting the market demand. Additionally, the excellent ability of mRNA to combine multiple molecules into a single therapeutic has gained significant attention from potential investors and the pharmaceutical industry, is again contributing the market growth. Challenges regarding unintended side effects may act as a restraint of market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of mRNA vaccine and therapeutics.
The broad mRNA vaccine and therapeutics market has been sub-grouped into end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- Infectious Disease
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for mRNA vaccine and therapeutics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on the demand for individual application segments in all the regions.
Global mRNA Vaccine And Therapeutics Market Share by Region (Representative Graph)
The report also covers a detailed competitive landscape including company profiles of key players operating in the global market. The key players in the mRNA vaccine and therapeutics market include Argos Therapeutics, BioNTech, CureVac, eTheRNA, Ethris, In-Cell-Art, Moderna Therapeutics, Sangamo Therapeutics, Tiba Biotechnology and Translate Bio. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.